26 February 2021
Electrochemical Plant (ECP), a subsidiary of Rosatom’s nuclear gas producer TVEL, recorded a 14% enhance in income from the sale of secure isotopes in 2020, exceeding RUB1.5 billion (USD20.1 million) for the primary time. The Zelenogorsk, Krasnoyarsk-based firm’s world market share of the secure isotope market stays over 40%, TVEL stated.
An isotope manufacturing facility at ECP (Picture: TVEL)
Steady isotopes are non-radioactive types of atoms. Though they don’t emit radiation, their distinctive properties allow them for use in a broad number of functions, together with water and soil administration, environmental research, vitamin evaluation research and forensics.
ECP produces 110 isotopes of 21 chemical parts to be used, amongst different fields, within the nuclear energy, medical and electronics sectors, in addition to for scientific analysis in chemistry, physics, biotechnology, meteorology, agricultural chemistry. Its world attain extends, for instance, to Canada, China, Germany, France, Kazakhstan, South Korea, Sweden, the USA and Uzbekistan. Most of ECP’s export contracts for secure isotopes are signed by means of Isotope JSC, Rosatom’s subsidiary for isotope gross sales and advertising and marketing.
“Regardless of the challenges arising from the worldwide pandemic, along with our colleagues from Isotope JSC, we have now met all of the contractual commitments undertaken, and undeterred by the truth that isotope merchandise have traditionally been provided beneath a fancy superior manufacturing and provide chain,” stated Sergey Karaulov, deputy director common for non-nuclear companies growth at ECP.
One of many “most marketable” merchandise within the firm’s portfolio, Molybdenum-100, is utilized each in scientific analysis and the radiopharmaceutical manufacturing chain. In 2020, the powder type of Molybdenum-100 was provided to new abroad initiatives creating cyclotron expertise to supply radioisotopes for medical functions.
“The isotope merchandise of Electrochemical Plant are extremely marketable globally,” stated Yuri Kudryavtsev, senior vice chairman for brand new companies growth at TVEL. “In pursuing this enterprise, unique competencies within the manufacturing of isotopes of excessive purity are utilized, whereas targets are set not solely to produce these distinctive supplies to the client but in addition to fabricate in-house merchandise of upper added worth. This refers to such initiatives because the manufacturing of cyclotron targets from Molybdenum-100 for nuclear medication functions, the manufacturing of breath assessments with Carbon-13 for medical diagnostics of the gastrointestinal tract, in addition to the manufacturing of ‘nuclear batteries’ primarily based on the Nickel-63 radioisotope,” he stated.
Researched and written by World Nuclear Information